Previous 10 | Next 10 |
InnovAge press release (NASDAQ:INNV): Q2 GAAP EPS of $0.01 misses by $0.03. Revenue of $175.35M (+11.5% Y/Y) beats by $1.41M. Center-level Contribution Margin of $41.4 million decreased 6.1% Y/Y. Adjusted EBITDA of $14.8M compared to $22.6M in the second quarter of fiscal 2021. For fur...
DENVER, Feb. 09, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced financial results for its fiscal second quarter ended Dece...
DENVER, Jan. 27, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV) will release its 2022 fiscal second quarter financial results on Wednesday, February 9, 2022, after market close. In conjunction, the company will host a conference call to review the ...
RM LAW Announces Investigation of InnovAge Holding Corp. PR Newswire BERWYN, Pa. , Jan. 11, 2022 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of InnovAge Holding Corp. ("InnovAge" or the "Company") (NA...
DENVER, Jan. 03, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV) accepted the resignation of longtime CEO and director Maureen Hewitt, effective January 1, 2022, who has decided after 15 years...
Gainers: Altamira Therapeutics (NASDAQ:CYTO) +21%, Regencell Bioscience (NASDAQ:RGC) +17%, BridgeBio Pharma BBIO +13%, ImmunityBio (NASDAQ:IBRX) +8%, BiondVax Pharmaceuticals BVXV +8%. Losers: Biofrontera (NASDAQ:BFRI) -21%, Microbot Medical (...
InnovAge (NASDAQ: INNV) is one company that will be very glad to see 2021 consigned to the history books. On Monday, the company's stock fell by 11%, on the back of two recommendation downgrades from prominent investment banks. The catalyst for the downgrades was InnovAge's disc...
Analyst comments factored heavily in Monday's midday action. InnovAge (NASDAQ:INNV) added to last week's losses following a downgrade, while Lucid Diagnostics (NASDAQ:LUCD) got a lift from a newly instated Buy rating. In other news, DiDi Global (NYSE:DIDI) suffered additional selling pressure...
Barclays analyst Sarah James downgraded InnovAge (NASDAQ:INNV) to Equal Weight from Overweight with a price target (PT) of $6.50, down from $22, after the company announced a sanction in its largest market, Colorado. Shares continue the downward trend, down 5% premarket after losing...
Stocks carried their recent optimism into the long holiday weekend, scoring modest gains on Thursday. The rally included Macau casino stocks, which rose on a promising signal from Chinese regulators. The news sparked gains in Melco Resorts & Entertainment (NASDAQ:MLCO), Las Vegas Sands (N...
News, Short Squeeze, Breakout and More Instantly...
InnovAge Holding Corp. Company Name:
INNV Stock Symbol:
OTCMKTS Market:
InnovAge Holding Corp. Website:
2024-07-08 00:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
DENVER, June 10, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (NASDAQ: INNV) (the “Company” or “InnovAge”) announced today that its Board of Directors has approved a share repurchase program (the “Program”) that authorizes the Company to repurchase up ...
DENVER, June 03, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE) has been recert...